A Microfluidic Platform for Evaluating Neutrophil Chemotaxis Induced by Sputum from COPD Patients

Chronic Obstructive Pulmonary Disease (COPD) is a common lung disease characterized by breathing difficulty as a consequence of narrowed airways. Previous studies have shown that COPD is correlated with neutrophil infiltration into the airways through chemotactic migration. However, whether neutrophil chemotaxis can be used to characterize and diagnose COPD is not well established. In the present study, we developed a microfluidic platform for evaluating neutrophil chemotaxis to sputum samples from COPD patients. Our results show increased neutrophil chemotaxis to COPD sputum compared to control sputum from healthy individuals. The level of COPD sputum induced neutrophil chemotaxis was correlated with the patient’s spirometry data. The cell morphology of neutrophils in a COPD sputum gradient is similar to the morphology displayed by neutrophils exposed to an IL-8 gradient, but not a fMLP gradient. In competing gradients of COPD sputum and fMLP, neutrophils chemotaxis and cell morphology are dominated by fMLP.

[1]  Deyu Li,et al.  A compact microfluidic gradient generator using passive pumping , 2012, Microfluidics and nanofluidics.

[2]  D. Beebe,et al.  The present and future role of microfluidics in biomedical research , 2014, Nature.

[3]  F. Lin.  Chapter 15 A Microfluidics‐Based Method for Analyzing Leukocyte Migration to Chemoattractant Gradients , 2009 .

[4]  Mehmet Toner,et al.  Microfluidic system for measuring neutrophil migratory responses to fast switches of chemical gradients. , 2006, Lab on a chip.

[5]  James J. Campbell,et al.  Multistep Navigation and the Combinatorial Control of Leukocyte Chemotaxis , 1997, The Journal of cell biology.

[6]  G. Whitesides,et al.  Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device , 2002, Nature Biotechnology.

[7]  Mehmet Toner,et al.  Microfluidics-Based Capture of Human Neutrophils for Expression Analysis in Blood and Bronchoalveolar Lavage , 2011, Laboratory Investigation.

[8]  A. Zychlinsky,et al.  Neutrophil function: from mechanisms to disease. , 2012, Annual review of immunology.

[9]  David J Beebe,et al.  Characterization of a membrane-based gradient generator for use in cell-signaling studies. , 2006, Lab on a chip.

[10]  M. Heinzelmann,et al.  Neutrophils and renal failure. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  C. Lenfant,et al.  Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .

[12]  N. Bissada,et al.  Impaired Neutrophil Chemotaxis in Diabetic Patients with Severe Periodontitis , 1981, Journal of dental research.

[13]  P. Jorens,et al.  Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. , 1993, The American journal of physiology.

[14]  Dong Wang,et al.  A stretching device for imaging real-time molecular dynamics of live cells adhering to elastic membranes on inverted microscopes during the entire process of the stretch. , 2010, Integrative biology : quantitative biosciences from nano to macro.

[15]  M. Saetta,et al.  Pathogenesis and Pathology of COPD , 2001, Respiration.

[16]  R. Crystal,et al.  Interleukin-8 gene expression in human bronchial epithelial cells. , 1991, The Journal of biological chemistry.

[17]  Shur-Jen Wang,et al.  Effective neutrophil chemotaxis is strongly influenced by mean IL-8 concentration. , 2004, Biochemical and biophysical research communications.

[18]  D. Beebe,et al.  Characterizing asthma from a drop of blood using neutrophil chemotaxis , 2014, Proceedings of the National Academy of Sciences.

[19]  F. Lin.  Chapter 15. A microfluidics-based method for chemoattractant gradients. , 2009, Methods in enzymology.

[20]  Mehmet Toner,et al.  Neutrophil migration assay from a drop of blood. , 2008, Lab on a chip.

[21]  F. Lin,et al.  Recent developments in microfluidics-based chemotaxis studies. , 2013, Lab on a chip.

[22]  P. Barnes,et al.  Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. , 2003, Chest.

[23]  V. Kumar,et al.  Neutrophils: Cinderella of innate immune system. , 2010, International immunopharmacology.

[24]  N. Jeon,et al.  Biological applications of microfluidic gradient devices. , 2010, Integrative biology : quantitative biosciences from nano to macro.

[25]  Francis Lin,et al.  A compact microfluidic system for cell migration studies , 2014, Biomedical microdevices.

[26]  R. Stockley,et al.  NEUTROPHILS FROM SUBJECTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE SHOW ENHANCED CHEMOTAXIS AND EXTRACELLULAR PROTEOLYSIS , 1987, The Lancet.

[27]  Mehmet Toner,et al.  Burn Injury Reduces Neutrophil Directional Migration Speed in Microfluidic Devices , 2010, PloS one.

[28]  Francis Lin,et al.  Neutrophil Migration in Opposing Chemoattractant Gradients Using Microfluidic Chemotaxis Devices , 2005, Annals of Biomedical Engineering.

[29]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[30]  T. Standiford,et al.  Effects of sepsis on neutrophil chemotaxis , 2010, Current opinion in hematology.

[31]  R. Djukanović,et al.  Impaired neutrophil chemotaxis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[32]  R. Stockley,et al.  Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of α1–antitrypsin deficiency and the role of leukotriene B4 and interleukin 8 , 2002, Thorax.

[33]  B. Heit,et al.  An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients , 2002, The Journal of cell biology.

[34]  S. Wasserman,et al.  Generation and partial characterization of eosinophil chemotactic activity and neutrophil chemotactic activity during early and late-phase asthmatic response. , 1986, The Journal of allergy and clinical immunology.

[35]  B. Chung,et al.  Generation of stable concentration gradients in 2D and 3D environments using a microfluidic ladder chamber , 2007, Biomedical microdevices.

[36]  A. Oudenaarden,et al.  Neutrophil chemorepulsion in defined interleukin‐8 gradients in vitro and in vivo , 2006, Journal of leukocyte biology.

[37]  T. Yoneda,et al.  Airway inflammation in COPD assessed by sputum levels of interleukin-8. , 1997, Chest.

[38]  R. Wysk,et al.  Interdigitated silver-polymer-based antibacterial surface system activated by oligodynamic iontophoresis – An empirical characterization study , 2014, Biomedical microdevices.

[39]  A. Condliffe,et al.  The neutrophil in chronic obstructive pulmonary disease. , 2013, American journal of respiratory cell and molecular biology.

[40]  E. Butcher,et al.  T cell chemotaxis in a simple microfluidic device. , 2006, Lab on a chip.

[41]  A. Yamauchi,et al.  Systematic single cell analysis of migration and morphological changes of human neutrophils over stimulus concentration gradients. , 2014, Journal of immunological methods.

[42]  Roman Stocker,et al.  Bacterial chemotaxis in linear and nonlinear steady microfluidic gradients. , 2010, Nano letters.

[43]  Shur-Jen Wang,et al.  A parallel-gradient microfluidic chamber for quantitative analysis of breast cancer cell chemotaxis , 2006, Biomedical microdevices.

[44]  R. Stockley.  Neutrophils and the pathogenesis of COPD. , 2002, Chest.

[45]  D. Adams,et al.  Chemokines: leucocyte recruitment and activation cytokines , 1997, The Lancet.

[46]  D. Beebe,et al.  Microfluidic kit-on-a-lid: a versatile platform for neutrophil chemotaxis assays. , 2012, Blood.